Xeris Biopharma Holdings, Inc. XERS Enterprise value
Enterprise value at other companies
Other financials
Where this comes from
Calculated from Xeris Biopharma Holdings, Inc.’s reported figures.
The official record: Xeris Biopharma Holdings, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Xeris Biopharma Holdings, Inc.'s enterprise value.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Xeris Biopharma Holdings, Inc.'s enterprise value?
- Xeris Biopharma Holdings, Inc. (XERS) reported enterprise value of $1.15B in Q1 2026.
- How has Xeris Biopharma Holdings, Inc.'s enterprise value changed year-over-year?
- Xeris Biopharma Holdings, Inc.'s enterprise value increased by 8.7% year-over-year, from $1.06B to $1.15B.
- What is the long-term trend for Xeris Biopharma Holdings, Inc.'s enterprise value?
- Over 5 years (2020 to 2025), Xeris Biopharma Holdings, Inc.'s enterprise value has grown at a 16.9% compound annual growth rate (CAGR), from $662.99M to $1.45B.
- What does enterprise value mean?
- Market capitalization plus total debt minus cash, at the quarter end. The cost to acquire the whole business — what an buyer pays for equity and debt, net of the cash they'd inherit.